ImmuCell Corporation Other Noncash Income (Expense)
ImmuCell Corporation (ICCC) reported Other Noncash Income (Expense) of $76.77 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2025-08-14
- ImmuCell Corporation other noncash income (expense) for the quarter ending 2025-06-30 was $38.77K, a 3.58% increase year-over-year.
- ImmuCell Corporation other noncash income (expense) for the quarter ending 2025-03-31 was $38.00K, a 1.50% increase year-over-year.
- ImmuCell Corporation other noncash income (expense) for the quarter ending 2024-12-31 was $37.44K, a 23743.95% increase year-over-year.
- ImmuCell Corporation other noncash income (expense) for the quarter ending 2024-09-30 was $37.44K.
- ImmuCell Corporation other noncash income (expense) for fiscal 2024 was $149.74K.
- ImmuCell Corporation other noncash income (expense) for fiscal 2023 was -$95.72K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $38.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $76.77K 10-Q · filed 2025-08-14 | $114.21K derived: sum of 3 quarters · filed 2025-08-14 | $151.64K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $38.00K 10-Q · filed 2025-05-14 | $75.43K derived: sum of 2 quarters · filed 2025-05-14 | $112.87K derived: sum of 3 quarters · filed 2025-05-14 | $150.30K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $37.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $74.87K derived: sum of 2 quarters · filed 2025-03-28 | $112.31K derived: sum of 3 quarters · filed 2025-08-14 | $149.74K 10-K · filed 2025-03-28 |
| 2024-09-30 | $37.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $74.87K derived: sum of 2 quarters · filed 2025-08-14 | $112.31K 10-Q · filed 2024-11-13 | $112.46K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $37.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $74.87K 10-Q · filed 2025-08-14 | $75.03K derived: sum of 3 quarters · filed 2025-08-14 | $8.05K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $37.44K 10-Q · filed 2025-05-14 | $37.59K derived: sum of 2 quarters · filed 2025-05-14 | -$29.39K derived: sum of 3 quarters · filed 2025-05-14 | -$49.69K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $157.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$66.82K derived: sum of 2 quarters · filed 2025-03-28 | -$87.13K derived: sum of 3 quarters · filed 2025-03-28 | -$95.72K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$66.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$87.29K derived: sum of 2 quarters · filed 2024-11-13 | -$95.88K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$20.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$28.90K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$8.60K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |